"Polyamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amine compounds that consist of carbon chains or rings containing two or more primary amino groups.
| Descriptor ID |
D011073
|
| MeSH Number(s) |
D02.092.782
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Polyamines".
Below are MeSH descriptors whose meaning is more specific than "Polyamines".
This graph shows the total number of publications written about "Polyamines" by people in this website by year, and whether "Polyamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyamines" by people in Profiles.
-
Florendo M, Figacz A, Srinageshwar B, Sharma A, Swanson D, Dunbar GL, Rossignol J. Use of Polyamidoamine Dendrimers in Brain Diseases. Molecules. 2018 Sep 03; 23(9).
-
Hayes CS, Shicora AC, Keough MP, Snook AE, Burns MR, Gilmour SK. Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol Res. 2014 Mar; 2(3):274-85.
-
Opitz AW, Czymmek KJ, Wickstrom E, Wagner NJ. Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells. Biochim Biophys Acta. 2013 Feb; 1828(2):294-301.
-
Karp JE, Blackford A, Smith BD, Alino K, Seung AH, Bola?os-Meade J, Greer JM, Carraway HE, Gore SD, Jones RJ, Levis MJ, McDevitt MA, Doyle LA, Wright JJ. Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Leuk Res. 2010 Jul; 34(7):877-82.
-
Chen Y, Weeks RS, Burns MR, Boorman DW, Klein-Szanto A, O'Brien TG. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma. Int J Cancer. 2006 May 01; 118(9):2344-9.
-
Shah N, Antony T, Haddad S, Amenta P, Shirahata A, Thomas TJ, Thomas T. Antitumor effects of bis(ethyl)polyamine analogs on mammary tumor development in FVB/NTgN (MMTVneu) transgenic mice. Cancer Lett. 1999 Nov 01; 146(1):15-23.
-
Gunnia UB, Amenta PS, Seibold JR, Thomas TJ. Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase. Kidney Int. 1991 May; 39(5):882-90.
-
Benovic JL, Stone WC, Caron MG, Lefkowitz RJ. Inhibition of the beta-adrenergic receptor kinase by polyanions. J Biol Chem. 1989 Apr 25; 264(12):6707-10.
-
Kuo BS, Korner G, Dryjski M, Bjornsson TD. Role of polyamines in the stimulation of synthesis and secretion of plasminogen activator from bovine aortic endothelial cells. J Cell Physiol. 1988 Oct; 137(1):192-8.
-
Herrera-Ornelas L, Porter C, Pera P, Greco W, Petrelli NJ, Mittelman A. A comparison of ornithine decarboxylase and S-adenosylmethionine decarboxylase activity in human large bowel mucosa, polyps, and colorectal adenocarcinoma. J Surg Res. 1987 Jan; 42(1):56-60.